Structure

2-Boc-1,2,3,4-tetrahydroisoquinoline-5-carboxylic acid

CAS
872001-50-8
Catalog Number
ACM872001508
Category
Other Products
Molecular Weight
277.315660 [g/mol]
Molecular Formula
C15H19NO4

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBOXYLIC ACID, 872001-50-8, 2-BOC-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBOXYLIC ACID, 3,4-Dihydro-1H-isoquinoline-2,5-dicarboxylic acid 2-tert-butyl ester, SureCN1857142, CTK7G2938, AB13373, AG-A-37379, QC-7293, AK-84108, KB-228513, D57112, N-BOC-5-HYDROXYCARBONYL-1,2,3,4-TETRAHYDROISOQUINOLINE, 2,5(1H)-ISOQUINOLINEDICARBOXYLIC ACID, 3,4-DIHYDRO-, 2-(1,1-DIMETHYLETHYL) ESTER, 2-(TERT-BUTOXYCARBONYL)-5-HYDROXYCARBONYL-1,2,3,4-TETRAHYDROISOQUINOLINE
IUPAC Name
2-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-1H-isoquinoline-5-carboxylic acid
SMILES
CC(C)(C)OC(=O)N1CCC2=C(C=CC=C2C1)C(=O)O
InChI Key
VSVCDLLWJXPCKF-UHFFFAOYSA-N
Exact Mass
277.13100
H-Bond Acceptor
4
H-Bond Donor
1

Downstream Synthesis Route 1

  • 872001-50-8
  • 1035218-35-9
  • 1035216-04-6

Reference: [1]Current Patent Assignee: ABBVIE INC - WO2008/76356, 2008, A1
Location in patent: Page/Page column 108
[2]Current Patent Assignee: ABBOTT LABORATORIES INC - WO2011/71570, 2011, A1
Location in patent: Page/Page column 135

Downstream Synthesis Route 2

  • 872001-50-8
  • 141104-65-6
  • 1092447-55-6

Reference: [1]Current Patent Assignee: SANOFI - WO2008/151211, 2008, A1
Location in patent: Page/Page column 86-87

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.